Stock listing

NASDAQ:HROW Harrow, Inc. Stock

Home listing (NASDAQ) of Harrow, Inc.

Follow Harrow, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HROW

$27.28 USD -1.47 (-5.1%)

Close on Oct 16, 2026

Past year -28.1% · daily closes, Oct 16, 2025 – Oct 16, 2026, adjusted for splits
Day range
$27.13 – $28.67 USDOct 16, 2026
Volume
560,466 sharesOct 16, 2026
Market value
$1.02B USDAt the close on Oct 16, 2026 · price × 37.49M shares outstanding
52-week range
$26.96 – $54.85 USDLowest and highest trades, Oct 17, 2025 – Oct 16, 2026
Harrow, Inc. logo
Ticker
NASDAQ:HROW
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Harrow (NASDAQ:HROW) Q2 2026 Earnings Call

    Tue, Aug 11, 2026 · 8:00 AM ET

    Watch Transcript

  • Harrow (NASDAQ:HROW) Q1 2026 Earnings Call

    Tue, May 12, 2026 · 8:00 AM ET

    Watch Transcript

  • Harrow (NASDAQ:HROW) Q4 2025 Earnings Call

    Tue, Mar 03, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Harrow Closes Acquisition of TYRVAYA®

Oct 5, 2026

Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO

Sep 30, 2026

Harrow to Participate in Three Investor Conferences in September

Sep 1, 2026

Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections

Aug 20, 2026

Harrow Announces Second Quarter 2026 Financial Results

Aug 10, 2026

Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

Aug 6, 2026

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Jul 27, 2026

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting

Jul 20, 2026

Harrow Announces Commercial Launch of BYOOVIZ® in the United States

Jul 1, 2026

Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare

Jun 10, 2026

All Harrow, Inc. news

Decks

Harrow, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
28 in the last 12 months · 192 in all · newest Oct 5, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Aug 11, 2026
Decks
55 decks · latest Aug 11, 2026

Where Harrow, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HROW · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HROWBOATSUnited StatesUSD
Frankfurt:3IPFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Harrow, Inc.